238 related articles for article (PubMed ID: 16118104)
1. Characteristics of patients with stage T1b incidental prostate cancer.
Argyropoulos A; Doumas K; Farmakis A; Aristas O; Kontogeorgos G; Lykourinas M
Scand J Urol Nephrol; 2005; 39(4):289-93. PubMed ID: 16118104
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b.
Masue N; Deguchi T; Nakano M; Ehara H; Uno H; Takahashi Y
Int J Urol; 2005 Dec; 12(12):1045-9. PubMed ID: 16409608
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668
[TBL] [Abstract][Full Text] [Related]
4. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia?
Voigt S; Hüttig F; Koch R; Propping S; Propping C; Grimm MO; Wirth M
Prostate; 2011 Sep; 71(12):1325-31. PubMed ID: 21308716
[TBL] [Abstract][Full Text] [Related]
7. Outcome of radical prostatectomy for incidental carcinoma of the prostate.
Melchior S; Hadaschik B; Thüroff S; Thomas C; Gillitzer R; Thüroff J
BJU Int; 2009 Jun; 103(11):1478-81. PubMed ID: 19076134
[TBL] [Abstract][Full Text] [Related]
8. Derivatives of prostate-specific antigen as predictors of incidental prostate cancer.
Froehner M; Buck LM; Koch R; Hakenberg OW; Wirth MP
BJU Int; 2009 Jul; 104(1):25-8. PubMed ID: 19191782
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
[TBL] [Abstract][Full Text] [Related]
10. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
Ornstein DK; Rao GS; Smith DS; Andriole GL
J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
[TBL] [Abstract][Full Text] [Related]
11. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
12. [Prostate cancer in the transition zone in sympatomatic patients with no rectal signs and negative peripheral zone biopsy].
Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Bueno Chomón G; Leal Hernández F; Bielsa Carrillo A; García Burgos J
Arch Esp Urol; 1998 Jun; 51(5):437-41. PubMed ID: 9675938
[TBL] [Abstract][Full Text] [Related]
13. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
Rydén L; Egevad L; Ekman P; Hellström M
Scand J Urol Nephrol; 2007; 41(4):302-7. PubMed ID: 17763221
[TBL] [Abstract][Full Text] [Related]
15. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
Bright EA; Manuel C; Goddard JC; Khan MA
Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
[TBL] [Abstract][Full Text] [Related]
16. Does laser ablation prostatectomy lead to oncological compromise?
Biers SM; Oliver HC; King AJ; Adamson AS
BJU Int; 2009 Feb; 103(4):454-7. PubMed ID: 18782304
[TBL] [Abstract][Full Text] [Related]
17. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
Tanaka Y; Aoyama H; Momose H; Ono T; Samma S; Tanaka N; Akiyama T; Tani Y; Masuda Y; Matsuki H; Tani M; Tanaka M
Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
[TBL] [Abstract][Full Text] [Related]
18. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
[TBL] [Abstract][Full Text] [Related]
19. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.
Descazeaud A; Peyromaure M; Salin A; Amsellem-Ouazana D; Flam T; Viellefond A; Debré B; Zerbib M
Eur Urol; 2008 Feb; 53(2):355-61. PubMed ID: 17611015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
